3.3.3. Application of Chatbots in the Domain of the Chronic Disease

Two studies focused on the domain of chronic disease [58,60].

Pernencar et al. [58] studied the field of e-Therapy and mobile apps integrated into healthcare systems. The study reviewed the connection between chatbots with inflammatory bowel disease patients' healthcare, with the goal of supporting the development of digital products for chronic diseases. The study highlighted that the chatbot technology for chronic disease self-management had high acceptance and usability levels. However, the chatbot ontology still needed strong guidelines for personalizing communication.

Sawad et al. [60] explored different conversational agents used in healthcare for chronic conditions, analyzing their communication technology, evaluation measures, and AI methods. They found that users provided positive feedback about the usefulness, satisfaction, and ease of use of conversational agents. However, there was still insufficient evidence to determine the efficacy of AI-enabled conversational agents for chronic health conditions due to the lack of reporting of technical implementation details.
